Adverse events associated with discontinuation of the biologics/classic systemic treatments for moderate-to-severe plaque psoriasis: data from the Spanish Biologics Registry, Biobadaderm

1. Belinchón, I.
2. Ramos, J.M.
3. Carretero, G.
4. Ferrándiz, C.
5. Rivera, R.
6. Daudén, E.
7. De la Cueva-Dobao, P.
8. Gómez-García, F.J.
9. Herrera-Ceballos, E.
10. Sánchez-Carazo, J.L.
11. López-Estebaranz, J.L.
12. Alsina, M.
13. Ferrán, M.
14. Torrado, R.
15. Carrascosa, J.M.
16. Llamas-Velasco, M.
17. Ortiz, P.L.
18. García-Doval, I.
19. Descalzo, M.A.